Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital and Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut.
Gastroenterology. 2021 Mar;160(4):1315-1329.e13. doi: 10.1053/j.gastro.2020.11.036. Epub 2020 Nov 20.
BACKGROUND & AIMS: Hepatic encephalopathy (HE) is a serious neurologic complication in patients with liver cirrhosis. Very little is known about the role of the meningeal lymphatic system in HE. We tested our hypothesis that enhancement of meningeal lymphatic drainage could decrease neuroinflammation and ameliorate HE.
A 4-week bile duct ligation model was used to develop cirrhosis with HE in rats. Brain inflammation in patients with HE was evaluated by using archived GSE41919. The motor function of rats was assessed by the rotarod test. Adeno-associated virus 8-vascular endothelial growth factor C (AAV8-VEGF-C) was injected into the cisterna magna of HE rats 1 day after surgery to induce meningeal lymphangiogenesis.
Cirrhotic rats with HE showed significantly increased microglia activation in the middle region of the cortex (P < .001) as well as increased neuroinflammation, as indicated by significant increases in interleukin 1β, interferon γ, tumor necrosis factor α, and ionized calcium binding adaptor molecule 1 (Iba1) expression levels in at least 1 of the 3 regions of the cortex. Motor function was also impaired in rats with HE (P < .05). Human brains of patients with cirrhosis with HE also exhibited up-regulation of proinflammatory genes (NFKB1, IbA1, TNF-α, and IL1β) (n = 6). AAV8-VEGF-C injection significantly increased meningeal lymphangiogenesis (P = .035) and tracer dye uptake in the anterior and middle regions of the cortex (P = .006 and .003, respectively), their corresponding meninges (P = .086 and .006, respectively), and the draining lymph nodes (P = .02). Furthermore, AAV8-VEGF-C decreased microglia activation (P < .001) and neuroinflammation and ameliorated motor dysfunction (P = .024).
Promoting meningeal lymphatic drainage and enhancing waste clearance improves HE. Manipulation of meningeal lymphangiogenesis could be a new therapeutic strategy for the treatment of HE.
肝性脑病(HE)是肝硬化患者的一种严重神经系统并发症。脑膜淋巴管系统在 HE 中的作用知之甚少。我们检验了这样一个假设,即增强脑膜淋巴引流可以减少神经炎症并改善 HE。
采用胆总管结扎 4 周的模型在大鼠中建立伴有 HE 的肝硬化。通过使用存档的 GSE41919 评估 HE 患者的脑炎症。通过转棒试验评估大鼠的运动功能。在手术后 1 天,将腺相关病毒 8-血管内皮生长因子 C(AAV8-VEGF-C)注射到 HE 大鼠的枕骨大孔中,以诱导脑膜淋巴管生成。
伴有 HE 的肝硬化大鼠的皮质中部区域显示出明显增加的小胶质细胞激活(P <.001),以及神经炎症的增加,这表现为至少在皮质的 3 个区域中的 1 个区域中白细胞介素 1β、干扰素 γ、肿瘤坏死因子 α 和离子钙结合衔接蛋白 1(Iba1)表达水平的显著增加。HE 大鼠的运动功能也受损(P <.05)。伴有 HE 的肝硬化患者的人脑也表现出促炎基因(NFKB1、Iba1、TNF-α 和 IL1β)的上调(n = 6)。AAV8-VEGF-C 注射显著增加脑膜淋巴管生成(P =.035)和皮质前区和中区的示踪染料摄取(P =.006 和.003,分别),相应脑膜(P =.086 和.006,分别)和引流淋巴结(P =.02)。此外,AAV8-VEGF-C 降低了小胶质细胞激活(P <.001)和神经炎症,并改善了运动功能障碍(P =.024)。
促进脑膜淋巴引流和增强废物清除可改善 HE。脑膜淋巴管生成的操作可能是治疗 HE 的一种新的治疗策略。